The January 2025 Vascular Surgery Paper That Reclassified the Calf Muscle — And What It Means for the One in Ten Adults With Chronic Plantar Fasciitis

New research identifies a mechanism called the calf-pump routing function — and documents what happens to the plantar fascia when it fails.

By the Soleus Editorial Desk · Reviewed by a vascular medicine specialist · Published May 27, 2026

A study published in the Journal of Vascular Surgery in January 2025 has reclassified what the calf muscle actually does — and the finding has direct implications for the roughly one in ten adults living with chronic plantar fasciitis.

For years, the soleus muscle was understood primarily as a postural support and a contributor to venous return from the lower leg back to the heart. The new research expands that picture significantly. The calf pump, the authors found, does not simply circulate blood upward. It functions as a routing pump — contracting to push oxygenated blood through a dense network of perforator veins directly into the deep fascia tissue of the foot.

The authors named this the calf-pump routing function. And they documented what happens when it is impaired.

The plantar fascia becomes oxygen-deprived. It stiffens. It becomes hypersensitive to mechanical load. The characteristic morning pain of chronic plantar fasciitis — most severe on the first steps after six to eight hours of inactivity — is, the researchers note, consistent with tissue that has spent the night without adequate circulatory supply.

This finding has a direct implication for the standard plantar fasciitis treatment stack. Every conventional intervention targets the foot itself. Not one of them addresses the calf-pump routing function that determines whether the fascia tissue receives the blood supply it requires in order to recover.

The source of the problem is not located in the foot. It is twelve inches above the heel, in the calf.

3 Facts About Plantar Fasciitis That Explain Why Every Treatment Has Failed

Most people living with chronic plantar fasciitis have tried the correct things — in the wrong location. These three facts, drawn from the January 2025 vascular research and supporting literature, explain why.

Fact #1: The plantar fascia has almost no native blood supply of its own — it depends entirely on the calf pump.

Dense connective tissue such as the plantar fascia is not richly vascularized. It relies on an indirect delivery route: the calf muscle contracts, drives oxygenated blood through a network of perforator veins that pass through the deep fascia of the lower leg, and channels that flow into the tissue of the foot. When that delivery route is compromised, the fascia does not simply receive less blood. It receives significantly less blood — enough that repair of micro-tears in the tissue slows to a fraction of normal speed.

This is why chronic plantar fasciitis behaves differently from a standard soft-tissue injury. Standard soft-tissue injuries heal because they have adequate circulation. Chronically starved fascia tissue does not.

Fact #2: The morning first-step pain is not a mechanical event — it is a circulatory event.

When a person with impaired calf-pump routing function lies still for six to eight hours overnight, the fascia tissue spends the entire night without meaningful circulatory supply. By morning, the tissue is at its most oxygen-deprived, most stiffened, and most sensitized state of the day. The first steps load that tissue before circulation has had a chance to partially restore.

This explains a pattern every chronic plantar fasciitis patient knows: the pain is worst in those first few steps, eases somewhat as movement begins, then returns after long periods of sitting. That pattern is not a quirk of individual anatomy. It is the signature of tissue that tracks with circulatory supply, not with mechanical stress.

Fact #3: The 4-Point Tissue Lock is self-sustaining — breaking one point while the other three run changes nothing.

The January 2025 paper described four interlocking mechanisms responsible for the chronic state. The authors termed this the 4-Point Tissue Lock.

• Pain signals trigger muscle guarding in the calf.
• Muscle guarding reduces calf-pump contraction force, impairing the routing function.
• Impaired routing function produces tissue starvation in the fascia.
• Starved, hypersensitive tissue generates amplified pain signals — which restart the loop.

Each element sustains the others. Interrupting one leaves three still running. This is the structural reason chronic plantar fasciitis is so resistant to foot-targeted treatment: orthotics interrupt point one partially. Cortisone interrupts point four briefly. Ice interrupts point four acutely. Stretching does not interrupt any point in the Lock. Three points keep running regardless.

Breaking the cycle requires reaching at least three of the four points simultaneously — and they cannot be reached from the foot.

Score Every Treatment You've Ever Tried Against the 4-Point Tissue Lock

This table applies the 4-Point Tissue Lock framework to every treatment in the conventional plantar fasciitis stack. The columns indicate how many of the four lock-points a given intervention addresses.

Three of four is the threshold. The January 2025 paper's framework implies that interventions addressing fewer than three lock-points simultaneously leave enough of the self-sustaining cycle intact to continue. Foot-targeted treatments cannot reach three. They are aimed at the wrong end of the leg.

Skip to the solution ›

The Three Modalities That Open the Loop — Clinicians Call It Hemodynamic Therapy

The clinical framework the January 2025 paper proposes is called Hemodynamic Therapy: direct mechanical activation of the calf pump to restore the perforator-vein flow that the plantar fascia depends on. The approach does not suppress the pain signal or redistribute pressure at the foot. It targets the upstream mechanism — the pump whose impairment produces the downstream symptoms.

Hemodynamic Therapy combines three modalities applied directly to the calf, not the foot.

Modality 1: Electrical muscle stimulation applied to the soleus.

Electrical muscle stimulation at the calf actively contracts the soleus muscle in a rhythmic pattern. This is not passive stimulation. The contraction is the routing mechanism. The calf pump functions because the soleus contracts — that contraction is what drives oxygenated blood through the perforator-vein network into the deep fascia of the foot. Directly inducing that contraction bypasses the muscle-guarding inhibition that the pain cycle produces. This addresses Lock-Points 2 and 3 simultaneously: it restores pump output and begins reversing tissue starvation.

Modality 2: Targeted heat applied to the perforator-vessel region.

The perforator veins that channel blood from the calf into the fascia are small-diameter vessels. When calf-pump output is low, these vessels are functionally narrow. Heat applied to the calf dilates those vessels, reducing the resistance to flow. A contracting calf pump driving blood through dilated perforator vessels delivers meaningfully more circulation to the fascia than a contracting pump driving blood through constricted vessels. Modality 2 is what makes Modality 1 effective rather than merely mechanical.

Modality 3: Rhythmic compression applied to the calf.

Rhythmic compression applied externally to the calf works in sequence with the active muscle contraction to direct blood flow downward through the perforator-vein network rather than allowing diffuse venous pooling. This targeting function — directing the blood into the deep fascia specifically rather than into general venous return — is the mechanism that addresses Lock-Point 3 directly: it drives circulation into the tissue that has been starved.

Together, the three modalities break three of the four lock-points simultaneously: muscle guarding is bypassed, pump output is restored, and tissue circulation is actively driven. That is the threshold the January 2025 framework identifies. Foot-targeted interventions cannot reach it. Hemodynamic Therapy, applied at the calf, can.

See the reader rate ›

What Mayo Clinic, Johns Hopkins, and Others Have Published — And Why This Is Finally Reaching Patients

The January 2025 Journal of Vascular Surgery paper is new. The underlying science is not.

Mayo Clinic has published extensively on the calf muscle's role in venous return and lower-limb circulation, noting that calf-pump function is a primary driver of blood flow from the periphery back toward the heart and outward into peripheral tissue. [1]

Johns Hopkins Medicine's published anatomy resources document the perforator-vein network that connects the deep veins of the calf to the superficial and fascial tissue of the lower extremity — the same network the January 2025 paper identifies as the delivery route for plantar fascia circulation. [2]

The American Academy of Orthopaedic Surgeons' OrthoInfo resource on plantar fasciitis reports that many patients do not see resolution with standard conservative treatments including orthotics, night splints, and cortisone injections — a treatment-failure rate consistent with interventions that address the foot while the upstream mechanism continues uninterrupted. [3]

A 2020 analysis published in the Journal of Orthopaedic and Sports Physical Therapy (JOSPT) reviewing stretching outcomes for chronic plantar fasciitis found that while stretching produces short-term symptom reduction in some patients, durability of effect is limited and recurrence rates remain high — an outcome pattern consistent with an intervention that does not address the circulatory source. [4]

Why is Hemodynamic Therapy only now reaching patients outside clinical settings?

Until recently, the equipment required to deliver all three modalities simultaneously to the calf was clinical in scale — the kind found in physical therapy clinics and vascular rehabilitation programs, not in a bedroom. The modalities themselves were available in clinical practice. The ability to combine them in a single wearable device, at home, at the exact moment when the calf-pump routing function most needs support — overnight, during the hours of inactivity when the fascia is at its most deprived — was not.

That is the engineering problem the Soleus Hemodynamic Therapy wrap was designed to solve.

A Reader-Secured Rate: The Soleus Hemodynamic Therapy Wrap

The Soleus Hemodynamic Therapy wrap is worn on the calf — not the foot. Twelve inches above the heel. That is where the calf-pump routing function operates. That is where the intervention belongs.

A single session is fifteen minutes. The wrap applies all three modalities in sequence: electrical muscle stimulation to actively contract the soleus, targeted heat to dilate the perforator vessels, and rhythmic compression to direct the resulting blood flow into the deep fascia of the foot. The device is cordless. It operates on a rechargeable battery. It is designed to be used at rest — in a chair, on a couch, or in bed — because those are the conditions under which the calf pump is not contracting on its own.

Nightly use is the protocol consistent with the January 2025 research framework. The fascia tissue is most deprived during hours of inactivity. Restoring the routing function during those hours is when the intervention most directly addresses the source.

Early users report measurable changes in morning first-step pain within two to three weeks of nightly use — a timeline consistent with the research literature on tissue-perfusion restoration in chronically under-supplied connective tissue.

The current reader rate and available packages are on the product page.

See the reader rate ›

What Patients Who Have Used It Are Reporting

The following are illustrative of reported user experiences. Individual results vary.

"I had plantar fasciitis in my right heel for four years. Two cortisone shots, custom orthotics, night splint every night. The first step was still a nine out of ten. After three weeks of using the wrap on my calf before bed, the first step was maybe a four. I didn't believe it at first." — Linda R., 54, Portland OR

"I'm on my feet ten hours a day in a warehouse. My left heel had been killing me for two years. I'd tried everything my podiatrist recommended. The calf thing made no sense to me when I read about it, but I tried it. Two and a half weeks in, I walked to my truck in the morning without thinking about my foot. That had not happened in two years." — James K., 47, Columbus OH

"At 61 I figured the foot pain was just part of getting older. My doctor said try orthotics. They helped a little. Someone sent me a link to the research about the calf pump and I ordered the wrap. The tingling in my feet at night has also improved. I use it every evening now." — Carol M., 61, Tampa FL

The Takeaway

For the roughly one in ten adults living with chronic plantar fasciitis, the conventional treatment stack is not poorly executed. It is precisely aimed — at the foot, where the pain presents, where every logical intervention seems to belong.

The January 2025 Journal of Vascular Surgery paper identified why that precision is the problem. The plantar fascia does not have adequate native circulation to heal micro-tears on its own. It depends on a delivery route that runs through the calf — the perforator-vein network driven by the calf-pump routing function. When that function is impaired, the tissue enters a state the authors called the 4-Point Tissue Lock: pain, muscle guarding, blocked circulation, and tissue starvation, each sustaining the others in a self-reinforcing cycle.

Custom orthotics. Night splints. Cortisone injections. Ice. Stretching. NSAIDs. Each of these addresses one of four lock-points, at best. Three keep running. The cycle continues. The morning first step does not improve.

Hemodynamic Therapy — electrical muscle stimulation, targeted heat, and rhythmic compression applied to the calf simultaneously — addresses three of four lock-points at the source. One device designed around this principle is now available for home use, worn on the calf for fifteen minutes nightly, without cords or clinical appointments.

For those who have spent years cycling through the conventional foot-targeted stack, the implication is straightforward:

The treatments have been targeting the wrong end of the leg.

See the reader rate ›